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In August 2007, a new bio-medical journal Genomic
Medicine was launched to capture the key developments in
genome sciences and technologies relevant to medicine and
human health. Since then, several major journals emerged
also to compete in the same conceptual space. Because,
many of the leading biomedical journals are affiliated with
major organisations (for example, the EMBO Journal,
Journal of ASHG, Journal of ESHG, National Academy of
Sciences, etc.), the future of Genomic Medicine depended
on successful partnership with an institution or organisa-
tion. In 2008, the Human Genome Organisation (HUGO),
one of the leading international science organisations,
entered discussions with Springer (the publisher for
Genomic Medicine), and the Editorial leadership of
Genomic Medicine, to assume responsibility for the jour-
nal. This proposal was formally accepted by the governing
HUGO Council held at the HGM2008 conference in
Hyderabad, India (2008), and by the broad editorial board
of Genomic Medicine. This merger was viewed as mutually
beneficial to ensure a unique place for a journal in the
competitive area of genomic medicine, and to provide
HUGO with a publication vehicle for its concepts and
ideas. The journal was renamed The HUGO Journal and
rebranded as the official publication for this international
organisation. The initial leadership of the journal was to be
shared by Dhavendra Kumar (University of Cardiff), and
Edison T. Liu (President, HUGO).
The HUGO Journal is focused on discoveries arising
from the basic, clinical, and population explorations of the
human genome, and genomes of organisms relevant to
human health. As such we wish to publish primary research
papers of the highest quality investigating topics in geno-
mic medicine. In depth review articles on important topics
pertinent to genomic medicine, human genetics, computa-
tional genomics, and genomic technologies will be fea-
tured. Because the HUGO Journal represents the voice of
the Human Genome Organisation, we will be publishing
key consensus reports and policy guidelines from HUGO
Council and its subcommittees. Because of its history, The
HUGO Journal will have the advantage of being fully
indexed in PubMed from the outset thus providing visi-
bility for all articles published in the journal.
Besides the current research articles, commentaries, and
reviews, several new sections will be offered to enhance the
exchange of information relevant to genomic scientists:
Data-bases: This section specifically encourages the
publication of the description and utility of specific genomic
databases. These reports will be fully indexed in PubMed.
Innovation Reports: These are short reports of \1,000
words that describe a specific finding of interest to the
genomics community. The focus is on early publication of
a highly innovative finding that may not have large scale
validation. This includes case reports of unique genotype-
phenotype associations.
The HUGO Journal welcomes article submissions in
many of the following categories:
• Genomic sciences and human disease: e.g., pharmac-
ogenomics, cancer genomics, genetics of Mendelian
disorders, genetics of complex diseases
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• Genome structure and genetic variation
• Comparative genomics between humans and other
organisms
• Microbial genomics of organisms pertinent to human
disease
• Population genetics
• Human evolution and migration
• Genome-to-systems strategies in systems biology
• Genomic technologies
• Genomics and genetic epidemiology
• Computational genomics
• Ethical, legal, and societal research relevant to genom-
ics and human genetics
• Science policy analyses pertinent to genomics and
genetics.
• Genomic and genetic research from emerging and
developing countries.
Our goal is for The HUGO Journal to become one of the
leading bio-medical journals reporting state of the art
developments in genome sciences and technologies as
applied to medicine and human health.
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